1. Home
  2. CLDX vs EVH Comparison

CLDX vs EVH Comparison

Compare CLDX & EVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • EVH
  • Stock Information
  • Founded
  • CLDX N/A
  • EVH 2011
  • Country
  • CLDX United States
  • EVH United States
  • Employees
  • CLDX N/A
  • EVH N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • EVH Other Consumer Services
  • Sector
  • CLDX Health Care
  • EVH Consumer Discretionary
  • Exchange
  • CLDX Nasdaq
  • EVH Nasdaq
  • Market Cap
  • CLDX 1.3B
  • EVH 1.1B
  • IPO Year
  • CLDX 2008
  • EVH 2015
  • Fundamental
  • Price
  • CLDX $20.66
  • EVH $9.02
  • Analyst Decision
  • CLDX Buy
  • EVH Strong Buy
  • Analyst Count
  • CLDX 9
  • EVH 14
  • Target Price
  • CLDX $50.00
  • EVH $16.93
  • AVG Volume (30 Days)
  • CLDX 843.8K
  • EVH 2.4M
  • Earning Date
  • CLDX 08-07-2025
  • EVH 08-07-2025
  • Dividend Yield
  • CLDX N/A
  • EVH N/A
  • EPS Growth
  • CLDX N/A
  • EVH N/A
  • EPS
  • CLDX N/A
  • EVH N/A
  • Revenue
  • CLDX $5,790,000.00
  • EVH $2,195,920,000.00
  • Revenue This Year
  • CLDX N/A
  • EVH N/A
  • Revenue Next Year
  • CLDX N/A
  • EVH $15.79
  • P/E Ratio
  • CLDX N/A
  • EVH N/A
  • Revenue Growth
  • CLDX N/A
  • EVH N/A
  • 52 Week Low
  • CLDX $14.40
  • EVH $7.06
  • 52 Week High
  • CLDX $47.00
  • EVH $33.63
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 40.75
  • EVH 38.96
  • Support Level
  • CLDX $20.65
  • EVH $9.14
  • Resistance Level
  • CLDX $22.60
  • EVH $9.72
  • Average True Range (ATR)
  • CLDX 1.11
  • EVH 0.53
  • MACD
  • CLDX -0.28
  • EVH -0.11
  • Stochastic Oscillator
  • CLDX 10.64
  • EVH 36.12

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

Share on Social Networks: